questionsmedicales.fr
Disciplines et activités comportementales
Psychothérapie
Thérapie comportementale
Désensibilisation psychologique
Désensibilisation psychologique : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Désensibilisation psychologique : Questions médicales les plus fréquentes",
"headline": "Désensibilisation psychologique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Désensibilisation psychologique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-16",
"dateModified": "2025-03-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Désensibilisation psychologique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Thérapie comportementale",
"url": "https://questionsmedicales.fr/mesh/D001521",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie comportementale",
"code": {
"@type": "MedicalCode",
"code": "D001521",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Désensibilisation et reprogrammation par mouvements oculaires",
"alternateName": "Eye Movement Desensitization Reprocessing",
"url": "https://questionsmedicales.fr/mesh/D057169",
"about": {
"@type": "MedicalCondition",
"name": "Désensibilisation et reprogrammation par mouvements oculaires",
"code": {
"@type": "MedicalCode",
"code": "D057169",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.506.162"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie implosive",
"alternateName": "Implosive Therapy",
"url": "https://questionsmedicales.fr/mesh/D007171",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie implosive",
"code": {
"@type": "MedicalCode",
"code": "D007171",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.506.325"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thérapie par réalité virtuelle",
"alternateName": "Virtual Reality Exposure Therapy",
"url": "https://questionsmedicales.fr/mesh/D063367",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie par réalité virtuelle",
"code": {
"@type": "MedicalCode",
"code": "D063367",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754.137.506.662"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Désensibilisation psychologique",
"alternateName": "Desensitization, Psychologic",
"code": {
"@type": "MedicalCode",
"code": "D003887",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Clare Stokes",
"url": "https://questionsmedicales.fr/author/Clare%20Stokes",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacology and Therapeutics, University of Florida, P.O. Box 100267, Gainesville, FL, 32610-0267, USA."
}
},
{
"@type": "Person",
"name": "Roger L Papke",
"url": "https://questionsmedicales.fr/author/Roger%20L%20Papke",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacology and Therapeutics, University of Florida, P.O. Box 100267, Gainesville, FL, 32610-0267, USA."
}
},
{
"@type": "Person",
"name": "Marija Rowane",
"url": "https://questionsmedicales.fr/author/Marija%20Rowane",
"affiliation": {
"@type": "Organization",
"name": "Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio."
}
},
{
"@type": "Person",
"name": "Robert Hostoffer",
"url": "https://questionsmedicales.fr/author/Robert%20Hostoffer",
"affiliation": {
"@type": "Organization",
"name": "Allergy Immunology Associates, Inc., Mayfield Heights, Ohio."
}
},
{
"@type": "Person",
"name": "Hye-Ryun Kang",
"url": "https://questionsmedicales.fr/author/Hye-Ryun%20Kang",
"affiliation": {
"@type": "Organization",
"name": "Seoul National University Hospital Regional Pharmacovigilance Center, Seoul, Korea; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea; Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul National University College of Medicine, Seoul, Korea. Electronic address: helenmed@snu.ac.kr."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Safety and efficacy of levonorgestrel-releasing intrauterine device in the treatment of atypical endometrial hyperplasia and early endometrial cancer.",
"datePublished": "2022-08-29",
"url": "https://questionsmedicales.fr/article/36054237",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jog.15408"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hysteroscopic biopsy compared with endometrial curettage to assess the preoperative rate of atypical hyperplasia underestimating endometrial carcinoma.",
"datePublished": "2023-05-09",
"url": "https://questionsmedicales.fr/article/37160470",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00404-023-07060-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Application of molecular classification to guiding fertility-sparing therapy for patients with endometrial cancer or endometrial intraepithelial neoplasia.",
"datePublished": "2022-12-19",
"url": "https://questionsmedicales.fr/article/36580798",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.prp.2022.154278"
}
},
{
"@type": "ScholarlyArticle",
"name": "FIGO staging of endometrial cancer: 2023.",
"datePublished": "2023-08-08",
"url": "https://questionsmedicales.fr/article/37593813",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3802/jgo.2023.34.e85"
}
},
{
"@type": "ScholarlyArticle",
"name": "Update in the molecular classification of endometrial carcinoma.",
"datePublished": "2023-03-06",
"url": "https://questionsmedicales.fr/article/36878561",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/ijgc-2022-003772"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Disciplines et activités comportementales",
"item": "https://questionsmedicales.fr/mesh/D004191"
},
{
"@type": "ListItem",
"position": 3,
"name": "Psychothérapie",
"item": "https://questionsmedicales.fr/mesh/D011613"
},
{
"@type": "ListItem",
"position": 4,
"name": "Thérapie comportementale",
"item": "https://questionsmedicales.fr/mesh/D001521"
},
{
"@type": "ListItem",
"position": 5,
"name": "Désensibilisation psychologique",
"item": "https://questionsmedicales.fr/mesh/D003887"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Désensibilisation psychologique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Désensibilisation psychologique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Désensibilisation psychologique",
"description": "Comment diagnostiquer une phobie spécifique ?\nQuels tests sont utilisés pour évaluer l'anxiété ?\nQuels critères DSM sont utilisés pour le diagnostic ?\nComment évaluer l'impact de la peur sur la vie quotidienne ?\nQuelle est la différence entre anxiété et phobie ?",
"url": "https://questionsmedicales.fr/mesh/D003887?mesh_terms=Endometrial+Neoplasms&page=4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Désensibilisation psychologique",
"description": "Quels sont les symptômes d'une phobie ?\nComment se manifeste l'anxiété anticipatoire ?\nQuels signes indiquent une crise d'angoisse ?\nComment reconnaître une réaction de stress aigu ?\nQuels symptômes sont associés à la désensibilisation ?",
"url": "https://questionsmedicales.fr/mesh/D003887?mesh_terms=Endometrial+Neoplasms&page=4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Désensibilisation psychologique",
"description": "Comment prévenir le développement d'une phobie ?\nQuels rôles jouent le soutien familial dans la prévention ?\nComment la thérapie préventive peut-elle aider ?\nQuels exercices de relaxation sont recommandés ?\nComment l'éducation émotionnelle contribue-t-elle à la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D003887?mesh_terms=Endometrial+Neoplasms&page=4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Désensibilisation psychologique",
"description": "Quels traitements sont efficaces pour la désensibilisation ?\nComment fonctionne la thérapie d'exposition ?\nQuels médicaments peuvent aider à réduire l'anxiété ?\nQuelle est l'importance de la thérapie de groupe ?\nComment la pleine conscience aide-t-elle à la désensibilisation ?",
"url": "https://questionsmedicales.fr/mesh/D003887?mesh_terms=Endometrial+Neoplasms&page=4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Désensibilisation psychologique",
"description": "Quelles complications peuvent survenir avec une phobie non traitée ?\nComment l'anxiété chronique affecte-t-elle la santé physique ?\nQuels risques sont associés à l'automédication ?\nComment la désensibilisation peut-elle échouer ?\nQuels effets secondaires peuvent résulter des médicaments ?",
"url": "https://questionsmedicales.fr/mesh/D003887?mesh_terms=Endometrial+Neoplasms&page=4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Désensibilisation psychologique",
"description": "Quels facteurs augmentent le risque de phobies ?\nComment le stress environnemental influence-t-il l'anxiété ?\nQuel rôle joue la génétique dans l'anxiété ?\nComment les expériences d'enfance affectent-elles l'anxiété ?\nQuels traits de personnalité sont liés à l'anxiété ?",
"url": "https://questionsmedicales.fr/mesh/D003887?mesh_terms=Endometrial+Neoplasms&page=4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une phobie spécifique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic se fait par l'évaluation des symptômes et l'historique médical du patient."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'anxiété ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des échelles d'anxiété comme l'échelle de Beck ou l'inventaire d'anxiété de Spielberger sont couramment utilisées."
}
},
{
"@type": "Question",
"name": "Quels critères DSM sont utilisés pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères DSM-5 incluent la peur intense, l'évitement et la durée des symptômes."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'impact de la peur sur la vie quotidienne ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "On évalue l'impact par des questionnaires sur le fonctionnement social et professionnel."
}
},
{
"@type": "Question",
"name": "Quelle est la différence entre anxiété et phobie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'anxiété est une réponse générale, tandis que la phobie est une peur intense d'un objet ou situation spécifique."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une phobie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent la peur intense, la transpiration, le tremblement et l'évitement."
}
},
{
"@type": "Question",
"name": "Comment se manifeste l'anxiété anticipatoire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par une inquiétude excessive avant une situation redoutée, souvent accompagnée de symptômes physiques."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une crise d'angoisse ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent palpitations, essoufflement, vertiges et peur de perdre le contrôle."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction de stress aigu ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se caractérise par des symptômes immédiats après un événement traumatique, comme l'anxiété et l'agitation."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à la désensibilisation ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure une réduction de l'anxiété et une meilleure tolérance aux stimuli redoutés."
}
},
{
"@type": "Question",
"name": "Comment prévenir le développement d'une phobie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation sur la gestion du stress et des techniques de relaxation peut aider à prévenir les phobies."
}
},
{
"@type": "Question",
"name": "Quels rôles jouent le soutien familial dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un soutien familial solide peut réduire le risque de développer des troubles anxieux chez les individus vulnérables."
}
},
{
"@type": "Question",
"name": "Comment la thérapie préventive peut-elle aider ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie préventive enseigne des compétences d'adaptation avant l'apparition des symptômes d'anxiété."
}
},
{
"@type": "Question",
"name": "Quels exercices de relaxation sont recommandés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des exercices comme la respiration profonde et la méditation peuvent aider à réduire l'anxiété."
}
},
{
"@type": "Question",
"name": "Comment l'éducation émotionnelle contribue-t-elle à la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation émotionnelle aide les individus à reconnaître et gérer leurs émotions, réduisant ainsi le risque d'anxiété."
}
},
{
"@type": "Question",
"name": "Quels traitements sont efficaces pour la désensibilisation ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie cognitivo-comportementale et l'exposition graduée sont des traitements efficaces."
}
},
{
"@type": "Question",
"name": "Comment fonctionne la thérapie d'exposition ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle consiste à exposer progressivement le patient à la source de sa peur pour réduire l'anxiété."
}
},
{
"@type": "Question",
"name": "Quels médicaments peuvent aider à réduire l'anxiété ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antidépresseurs et les anxiolytiques sont souvent prescrits pour gérer l'anxiété."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de la thérapie de groupe ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie de groupe offre un soutien social et des stratégies d'adaptation partagées entre les participants."
}
},
{
"@type": "Question",
"name": "Comment la pleine conscience aide-t-elle à la désensibilisation ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La pleine conscience aide à gérer l'anxiété en permettant au patient de se concentrer sur le moment présent."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une phobie non traitée ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'isolement social, la dépression et des troubles de l'alimentation."
}
},
{
"@type": "Question",
"name": "Comment l'anxiété chronique affecte-t-elle la santé physique ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'anxiété chronique peut entraîner des problèmes de santé comme des maladies cardiaques et des troubles digestifs."
}
},
{
"@type": "Question",
"name": "Quels risques sont associés à l'automédication ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'automédication peut aggraver les symptômes et entraîner une dépendance aux substances."
}
},
{
"@type": "Question",
"name": "Comment la désensibilisation peut-elle échouer ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "La désensibilisation peut échouer si le patient ne s'engage pas pleinement dans le processus thérapeutique."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires peuvent résulter des médicaments ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure la somnolence, des nausées et des troubles de la mémoire."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de phobies ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, les expériences traumatiques et le tempérament anxieux augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment le stress environnemental influence-t-il l'anxiété ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress environnemental, comme les conflits familiaux, peut exacerber les symptômes d'anxiété."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la génétique dans l'anxiété ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "La génétique peut prédisposer certains individus à des troubles anxieux, influençant leur réponse au stress."
}
},
{
"@type": "Question",
"name": "Comment les expériences d'enfance affectent-elles l'anxiété ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des expériences d'enfance négatives, comme l'abus, peuvent augmenter le risque de troubles anxieux à l'âge adulte."
}
},
{
"@type": "Question",
"name": "Quels traits de personnalité sont liés à l'anxiété ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traits comme le névrosisme et la timidité sont souvent associés à un risque accru d'anxiété."
}
}
]
}
]
}
To investigate the recurrence rate, live-birth rate, and treatment outcomes of levonorgestrel-releasing intrauterine device (LNG-IUD) for the management of atypical endometrial hyperplasia (AEH) or Gr...
We prospectively enrolled nine patients from a single institution between April 2009 and September 2013 who were followed up for 60 months after LNG-IUD insertion....
The median patient age was 35 (range: 29-39) years. The overall recurrence rate was 56% (5/9). The median interval between removal of the LNG-IUD and recurrence was 20.5 (range: 2-30) months. Three of...
LNG-IUD is effective for the management of AEH and EC in young patients who desire fertility-sparing treatment, including those ineligible for MPA owing to the presence of comorbidities and those with...
To evaluate the rate of atypical hyperplasia (AH) underestimating endometrial cancer (EC) comparing endometrial biopsy (EB) accomplished by hysteroscopic biopsy with dilatation and curettage (D&C). Se...
This trial was based on the findings of two Gynecological Departments within the same Public Utility, sharing pathological service and database but routinely performing EB under hysteroscopic visualiz...
A total of 161 patients met the inclusion criteria. Among these, 109 and 52 were included in groups A and B, respectively. In group A, 32.1% of patients underwent EB in an out-patient setting. To fore...
EB performed by D&C lowers the rate of AH underestimating concurrent EC and improves the grading agreement when compared with hysteroscopic sampling....
The aim of this study was to evaluate whether molecular classification was associated with treatment response in women with endometrial endometrioid carcinoma (EEC) or Endometrial atypical hyperplasia...
A retrospective analysis of 59 patients with EEC or EAH/EIN who received fertility-sparing therapy between 2013 and 2021 was performed. For each patient, medical records and pathological reports were ...
23 of 39 patients with EEC received complete response (CR) after fertility-sparing treatment which was significantly lower than the EAH/EIN group (58.97 % vs 80.0 %, P < 0.05). Molecular classificatio...
Molecular classification of EAH/EIN prior to management with progestin treatment was feasible and may predict patients at risk of progression....
Many advances in the understanding of the pathologic and molecular features of endometrial cancer have occurred since the FIGO staging was last updated in 2009. Substantially more outcome and biologic...
The FIGO Women's Cancer Committee appointed a Subcommittee on Endometrial Cancer Staging in October 2021, represented by the authors. Since then, the committee members have met frequently and reviewed...
Based on the existing evidence, the substages were defined as follows:...
The updated 2023 staging of endometrial cancer includes the various histological types, tumor patterns, and molecular classification to better reflect the improved understanding of the complex nature ...
The pathological classification of endometrial carcinomas, one of the cornerstones in patient clinical management, has traditionally been based on morphologic features. However, this classification sy...
This article reviews treatments and targets of interest in endometrial cancer by molecular subtype. The Cancer Genome Atlas (TCGA) classifies four molecular subtypes-mismatch repair deficient (dMMR)/m...
Endometrial cancer is the most common malignancy of the female genital tract. Obesity is a strong risk factor for endometrial cancer. Adipose tissue is an active endocrine organ that synthesizes biolo...
Cancer cells are usually featured by metabolic adaptations that facilitate their growth, invasion, and metastasis. Thus, reprogramming of intracellular energy metabolism is currently one of the hotspo...
Endometrial cancer (EC) is common malignancy in women and its incidence is slowly on the rise. Accurate surgical staging, with aggressive cytoreduction when indicated, remains the most critical step i...
Many advances in the understanding of the pathologic and molecular features of endometrial cancer have occurred since the FIGO staging was last updated in 2009. Substantially more outcome and biologic...
The FIGO Women's Cancer Committee appointed a Subcommittee on Endometrial Cancer Staging in October 2021, represented by the authors. Since then, the committee members have met frequently and reviewed...
Based on the existing evidence, the substages were defined as follows: Stage I (IA1): non-aggressive histological type of endometrial carcinoma limited to a polyp or confined to the endometrium; (IA2)...
The updated 2023 staging of endometrial cancer includes the various histological types, tumor patterns, and molecular classification to better reflect the improved understanding of the complex nature ...